• Business Update: Motif Bio

News & Views

Business Update: Motif Bio

Jan 05 2021

Reclassified as an AIM Rule 15 cash shell, following completion of restructuring approved by shareholders in November 2019, Motif Bio plc (AIM: MTFB), announces a business update regarding progress towards completing a reverse take-over pursuant to AIM Rule 14 (“RTO”).

The Company is currently advancing the necessary work streams to complete the RTO process with a UK based candidate in the healthcare sector.  The Board expects to provide shareholders with a further update during the second half of January.

Following its reclassification as an AIM Rule 15 cash shell in January 2020, the Company is required to make an acquisition which constitutes a RTO by 28 January 2021, failing which the Company's admission to trading on AIM may be cancelled. At this stage, there can be no assurance that the Company will be able to complete this or any other RTO transaction.

The person responsible for the release of this announcement on behalf of Motif Bio is Jonathan Gold, President and Chief Business Officer.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.


Digital Edition

International Labmate Buyers' Guide 2024/25

June 2024

Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...

View all digital editions

Events

HPLC 2024

Jul 20 2024 Denver, CO, USA

ICMGP 2024

Jul 21 2024 Cape Town, South Africa

ADLM 2024

Jul 28 2024 San Diego, CA USA

InaLab 2024

Jul 30 2024 Jakarta, Indonesia

Miconex

Jul 31 2024 Chengdu, China

View all events